Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 1 486.6 INR -1.87% Market Closed
Market Cap: 12.7B INR

Wall Street
Price Targets

HESTERBIO Price Targets Summary
Hester Biosciences Ltd

There are no price targets for HESTERBIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hester Biosciences Ltd Competitors:
Price Targets
PEB
Pacific Edge Ltd
31% Downside
VITR
Vitrolife AB
45% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
57% Upside
AMGN
Amgen Inc
5% Upside
SBTX
SkinBioTherapeutics PLC
58% Upside
BIOCON
Biocon Ltd
17% Upside
FDMT
4D Molecular Therapeutics Inc
309% Upside
005690
Pharmicell Co Ltd
23% Upside

Revenue
Forecast

Revenue Estimate
Hester Biosciences Ltd

For the last 13 years the compound annual growth rate for Hester Biosciences Ltd's revenue is 15%.

15%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hester Biosciences Ltd

For the last 13 years the compound annual growth rate for Hester Biosciences Ltd's operating income is 9%. The projected CAGR for the next 5 years is 10%.

9%
Past Growth
10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Hester Biosciences Ltd

For the last 13 years the compound annual growth rate for Hester Biosciences Ltd's net income is 10%.

10%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HESTERBIO's stock price target?
Not Available

HESTERBIO doesn't have any price targets made by Wall Street professionals.

What is Hester Biosciences Ltd's Operating Income forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Hester Biosciences Ltd's operating income is 9%. The projected CAGR for the next 5 years is 10%.

Back to Top